Nav: Home

RNA splicing mutations play major role in genetic variation and disease

April 28, 2016

RNA splicing is a major underlying factor that links mutations to complex traits and diseases, according to an exhaustive analysis of gene expression in whole genome and cell line data. Reporting in Science on April 29, 2016 researchers from the University of Chicago and Stanford University studied how thousands of mutations affect gene regulation in traits such as height, and diseases such as multiple sclerosis. The findings highlight the need for a better understanding of the role of RNA splicing on variation in complex traits and disease, and enable more accurate functional interpretations of genome-wide association study results.

"We were able to comprehensively identify how mutations perturb gene expression all the way from transcription to translation, and how they affect different regulatory mechanisms," said Yoav Gilad, PhD, professor of human genetics at the University of Chicago and co-senior author of the study. "We found that a significant proportion of the associations between mutation and variation in disease is explained by effects on RNA splicing. We can now work to better understand this relationship and add another tool in our kit to figure out the biological mechanisms that cause disease."

Over the past decade, genome-wide association studies (GWAS) have been remarkably successful at revealing variations in the human genome that are associated with biological traits and complex diseases. These numerous single-letter mutations, known as quantitative trait loci (QTL), are mostly found in regions outside genes and are assumed to play a role in gene regulation. However, the functional significance of the vast majority of QTLs is unclear.

To take a comprehensive look at the underlying roles of genetic variants, Gilad and his colleagues, co-led by Jonathan Pritchard, PhD, professor of genetics at Stanford University, applied a suite of powerful statistical tools toward whole genome and cell line data gathered from 70 individuals. In a series of experiments that spanned eight years, they analyzed QTLs associated with seven regulatory phenotypes, including gene expression levels, RNA transcription and protein translation. For each regulatory phenotype, the team identified QTLs and quantified their effect on almost every step of gene regulation. They found that many of the QTLs overlapped in their effect on transcription, translation and ultimately protein levels.

"We have never considered so many data sets from a population sample of the exact same individuals before, so this type of analysis was never done," Gilad said.

The researchers, led by study author Yang Li, also developed a new computational method, called LeafCutter, which for the first time enables the effective identification of QTLs that are specifically involved in RNA splicing. All genes undergo splicing, where a precursor form of mRNA is cut and re-stitched together into numerous combinations. This significantly increases the number of proteins a single gene can code for and is thought to explain much of the complexity in higher-order organisms. At least 15 percent of all human diseases are thought to be due to splicing errors. However, until LeafCutter, no methodology existed to effectively identify and analyze splicing QTLs.

The team's analysis revealed almost three thousand splicing-specific QTLs, and many appear to play a major contributing role in the biology of genetic traits and disease. Splicing QTLs were most enriched in multiple sclerosis, and for other traits were roughly equal in influence with QTLs that affect global gene expression levels. Many of the splicing QTLs did not affect gene expression levels, suggesting that RNA splicing is a separate, but equally important, mechanism that underlies complex traits and disease.

"We now have a new appreciation for how important splicing is for disease," Gilad said. "Intuitively, we had assumed it is important, but we didn't really have a lot of genome-wide evidence until this study."

The results provide the first comprehensive data for RNA splicing as an important link between genetic variation and disease. Importantly, genetic variants identified through GWAS can now be assayed for potential roles in RNA splicing. If only overall gene expression is measured, the function of many of these sites would remain opaque.

"When we incorporate more information about more mechanisms in more diseases, we can better understand how genetic variation drives disease and someday perturb or fix that process," Gilad said. "We clearly have to consider RNA splicing now in addition to gene expression, histone accessibility and other factors, as we try to learn these rules."
The study, "RNA splicing is a primary link between genetic variation and disease," was supported by NIH grants R01MH084703, RO1MH101825, U01HG007036, and U54CA149145, a Stanford Center for Computational, Evolutionary and Human Genomics Fellowship, and the Howard Hughes Medical Institute. Additional authors include Bryce van de Geijn, Anil Raj, David A. Knowles, Allegra A. Petti and David Golan.

University of Chicago Medical Center

Related Multiple Sclerosis Articles:

New biomarkers of multiple sclerosis pathogenesis
Multiple sclerosis (MS) is a chronic debilitating inflammatory disease targeting the brain.
Using telemedicine to treat multiple sclerosis
Multiple sclerosis (MS) clinicians face continued challenges in optimizing neurological care, especially for people with advanced MS living in medically underserved communities.
Improving symptom tracking in multiple sclerosis
With a recent two-year, $833,000 grant from the US Department of Defense, kinesiology professor Richard van Emmerik and colleagues at the University of Massachusetts Amherst hope to eventually help an estimated 1 million people worldwide living with progressive multiple sclerosis by creating an improved diagnostic test for this form of the disease, which is characterized by a steady decrease in nervous system function.
An antibody-based drug for multiple sclerosis
Inserm Unit U919, directed by Professor Denis Vivien has developed an antibody with potential therapeutic effects against multiple sclerosis.
Four new risk genes associated with multiple sclerosis discovered
Scientists of the Technical University of Munich and the Max Planck Institute of Psychiatry have identified four new risk genes that are altered in German patients with multiple sclerosis.
PET detects neuroinflammation in multiple sclerosis
The triggers of autoimmune inflammation in multiple sclerosis (MS) have eluded scientists for many years, but molecular imaging is bringing researchers closer to identifying them, while providing a means of evaluating next-generation therapies for MS, say researchers introducing a study at the 2016 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging.
Scientists find genetic cause of multiple sclerosis
Researchers have discovered a rare genetic mutation that makes it probable that a person will develop multiple sclerosis (MS).
ANKRD55: A new gene involved in Multiple Sclerosis is discovered
The Ikerbasque researcher Koen Vandenbroeck, who heads the Neurogenomiks laboratory which reports to the Achucarro centre and the UPV/EHU-University of the Basque Country, together with other national and international groups, has shown that a genetic variant in the 5q11 chromosome, which is associated with susceptibility to developing multiple sclerosis, greatly regulates a gene known as ANKRD55.
Children with and without multiple sclerosis have differences in gut bacteria
In a recent study, children with multiple sclerosis had differences in the abundance of specific gut bacteria than children without the disease.
Rituximab is superior to fingolimod for certain patients with multiple sclerosis
A new study indicates that rituximab is more effective than fingolimod for preventing relapses in patients with highly active multiple sclerosis switching from treatment with natalizumab.

Related Multiple Sclerosis Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Digital Manipulation
Technology has reshaped our lives in amazing ways. But at what cost? This hour, TED speakers reveal how what we see, read, believe — even how we vote — can be manipulated by the technology we use. Guests include journalist Carole Cadwalladr, consumer advocate Finn Myrstad, writer and marketing professor Scott Galloway, behavioral designer Nir Eyal, and computer graphics researcher Doug Roble.
Now Playing: Science for the People

#529 Do You Really Want to Find Out Who's Your Daddy?
At least some of you by now have probably spit into a tube and mailed it off to find out who your closest relatives are, where you might be from, and what terrible diseases might await you. But what exactly did you find out? And what did you give away? In this live panel at Awesome Con we bring in science writer Tina Saey to talk about all her DNA testing, and bioethicist Debra Mathews, to determine whether Tina should have done it at all. Related links: What FamilyTreeDNA sharing genetic data with police means for you Crime solvers embraced...